Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Activity of Avenova as Skin Prep
NCT02990013Phase 1Completed
- Sponsor
- University of Miami
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hypochlorous acid in surgical site infection (SSI), sponsored by University of Miami. Primary endpoint: Efficacy of Avenova vs standard of care cleansing agents: growth vs. no growth at 12 months. Started Dec 2018; status: completed.
02
Drugs
hypochlorous acid
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02990013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02990013.